Matt Zeller, Novartis country president for Australia and New Zealand, said, “Over the past 35 years, and looking forward, we will continue to deliver innovative treatments to those with breast cancer. We join the national call for zero deaths from this disease in Australia."
TGA approves Novartis therapy for most commonly diagnosed type of early breast cancer
March 17, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
‘Game-changer’ clinical trial launches for Australia’s second-deadliest cancer
April 29, 2025 - - Latest News -
These system-shifting therapies come along every few years, but this is different
April 29, 2025 - - Latest News -
Culture review delivers a scathing assessment of New Zealand's Pharmac
April 29, 2025 - - Latest News -
Pfizer-commissioned survey reveals rising GP concerns over medical misinformation
April 29, 2025 - - Latest News -
New survey confirms significant interest in accessing weight loss therapies
April 28, 2025 - - Latest News -
Medicines Australia announces appointment of communications director
April 28, 2025 - - Latest News -
Recce Pharmaceuticals enters research and development agreement with US defence
April 28, 2025 - - Australian Biotech